Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation.
NCT06197763
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Fontan Circulation
Interventions
DRUG:
Colesevelam
OTHER:
Control Arm
Sponsor
St. Boniface Hospital